Abstract
As the “powerhouse” of a cell, mitochondria maintain energy homeostasis, synthesize ATP via oxidative phosphorylation, generate ROS signaling molecules, and modulate cell apoptosis. Herein, three Re(I) complexes bearing guanidinium derivatives have been synthesized and characterized. All of these complexes exhibit moderate anticancer activity in HepG2, HeLa, MCF-7, and A549 cancer cells. Mechanism studies indicate that complex 3, [Re(CO)3(L)(Im)](PF6)2, can selectively localize in the mitochondria and induce cancer cell death through mitochondria-associated pathways. In addition, complex 3 can effectively depress the ability of cell migration, cell invasion, and colony formation.
Graphic abstract
Similar content being viewed by others
References
Guerra F, Arbini AA, Moro L (2017) Biochim Biophys Acta 1858:686–699
Galluzzi L, Morselli E, Kepp O, Vitale I, Rigoni A, Vacchelli E, Michaud M, Zischka H, Castedo M, Kroemer G (2009) Mol Asp Med 31:1–20
Kumar R, Han J, Lim HJ, Ren WX, Lim JY, Kim JH, Kim JS (2014) J Am Chem Soc 136:17836–17843
Fulda S, Galluzzi L, Kroemer G (2010) Nat Rev Drug Discov 9:447–464
Battogtokh G, Choi YS, Kang DS, Park SJ, Shim MS, Huh KM, Cho YY, Lee JY, Lee HS, Kang HC (2018) Acta Pharm Sin B 8:862–880
Sakuma M, Fuchi Y, Usui K, Karasawa S (2019) Chem Asian J 14:3938–3945
Ye RR, Cao JJ, Tan CP, Ji LN, Mao ZW (2017) Chem Eur J 23:15166–15176
Liu JP, Chen Y, Li GY, Zhang PY, Jin CZ, Zeng LL, Ji LN, Chao H (2015) Biomaterials 56:140–153
Knopf KM, Murphy BL, MacMillan SN, Baskin JM, Barr MP, Boros E, Wilson JJ (2017) J Am Chem Soc 139:14302–14314
Kitanovic I, Can S, Alborzinia H, Kitanovic A, Pierroz V, Leonidova A, Pinto A, Spingler B, Ferrari S, Molteni R, Steffen A, Metzler-Nolte N, Wölfl S, Gasser G (2014) Chem Eur J 20:2496–2507
Yang J, Cao Q, Zhang H, Hao L, Zhou D, Gan Z, Li Z, Tong YX, Ji LN, Mao ZW (2018) Biomaterials 176:94–105
He L, Pan ZY, Qin WW, Li Y, Tan CP, Mao ZW (2019) Dalton Trans 48:4398–4404
Yip MH, Lo KW (2018) Coord Chem Rev 361:138–163
Capper MS, Enriquez Garcia A, Macia N, Lai B, Lin JB, Nomura M, Alihosseinzadeh A, Ponnurangam S, Heyne B, Shemanko CS, Jalilehvand F (2020) J Biol Inorg Chem 25:759–776
Leonidova A, Gasser G (2014) ACS Chem Biol 9–10:2180–2193
Capper MS, Packman H, Rehkämper M (2020) ChemBioChem 21:2111–2115
Konkankit CC, Vaughn BA, Huang Z, Boros E, Wilson JJ (2020). Dalton Trans. https://doi.org/10.1039/d0dt01097a
Wheate NJ, Walker S, Craig GE, Oun R (2010) Dalton Trans 39:8113–8127
Bergamo A, Sava G (2011) Dalton Trans 40:7817–7823
Kostova I (2009) Anti-Cancer Agents Med Chem 9:827–842
Lo KK (2015) Acc Chem Res 48:2985–2995
Lo KK, Zhang KY, Li SP (2011) Eur J Inorg Chem 24:3551–3568
Mishra A, Batra S (2013) Curr Top Med Chem 13:2011–2025
Liu Z, Sadler PJ (2014) Accounts Chem Res 47:1174–1185
Leung CH, Zhong HJ, Chan DSH, Ma DL (2013) Coord Chem Rev 257:1764–1776
Chen WX, Song XD, Chen JX, Zhao XH, Xing JH, Ren JR, Wu T, Sun J (2016) Polyhedron 110:274–281
Louie MW, Fong TTH, Lo KKW (2011) Inorg Chem 50:9465–9471
Li CY, Yu MX, Sun Y, Wu YQ, Huang CH, Li FY (2011) J Am Chem Soc 133:11231–11239
Puckett CA, Barton JK (2008) Biochemistry 47:11711–11716
Trachootham D, Alexandre J, Huang P (2009) Nat Rev Drug Discov 8:579–591
Cao JJ, Tan CP, Chen MH, Wu N, Yao DY, Liu XG, Ji LN, Mao ZW (2017) Chem Sci 8:631–640
DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB (2008) Cell Metab 7:11–20
Yan YY, Su XD, Liang YJ, Zhang JY, Shi CJ, Lu Y, Gu LQ, Fu LW (2008) Mol Cancer Ther 7:1688–1697
Jänicke RU, Sprengart ML, Wati MR, Porter AG (1998) J Biol Chem 273:9357–9360
Kwong WL, Lam KY, Lok CN, Lai YT, Lee PY, Che CM (2016) Angew Chem Int Ed Engl 55:13524–13528
Liang XJ, Choi Y, Sackett DL, Park JK (2008) Cancer Res 68:5267–5272
Wang FX, Chen MH, Lin YN, Zhang H, Tan CP, Ji LN, Mao ZW (2017) Appl Mater Interfaces 9:42471–42481
Xu XL, Li SQ, Lin YW, Chen JH, Xie LP (2013) Transl Med 11:276–288
Zhang J, Liu H, Hou LD, Wang G, Zhang R, Huang YX, Chen XY, Zhu JS (2017) Mol Cancer 16:151–159
Xu XL, Li SQ, Lin YW, Chen H, Hu ZH, Mao YQ, Xu X, Wu J, Zhu Y, Zheng XY, Luo JD, Xie LD (2013) J Transl Med 11:276–284
Pilkington GJ, Parker K, Murray SA (2008) Semin Cancer Biol 18:226–235
Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN (1993) Semin Cancer Biol 4:327–332
Su YT, Chang HL, Shyue SK, Lan SH (2005) Biochem Pharmacol 70:229–241
Ow YL, Green DR, Hao Z, Mak TW (2008) Nat Rev Mol Cell Biol 9:532–542
Lewis JS, Meeke K, Osipo C, Ross EA, Kidawi N, Li T, Bell E, Chandel NS, Jordan VC (2005) J Natl Cancer Inst 97:1746–1759
Acknowledgments
This work was supported by the National Natural Science Foundation of China (21101034), the Science and Technology Plan of Guangdong Province (2016A020217020), the Scientific Research Project of Guangdong Provincial Bureau of Traditional Chinese Medicine (20182070), and “Group-type” special support project for Education Talents in University (4SG19045G, 4SG19053G and 4SG19057G).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing financial interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Appendix A. Supplementary data:
The detailed experimental methods and other supplementary data related to this article can be found in the Electronic Supplementary Material (ESM) (PDF 951 kb)
Rights and permissions
About this article
Cite this article
He, SF., Pan, NL., Chen, BB. et al. Mitochondria-targeted Re(I) complexes bearing guanidinium as ligands and their anticancer activity. J Biol Inorg Chem 25, 1107–1116 (2020). https://doi.org/10.1007/s00775-020-01827-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-020-01827-7